BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the majority of patients previously treated with a covalent BTK...

Once-in-a-generation celebration will feature never-before-seen immersive experiences, 1,000 Bells of Freedom, seven celebration areas, four live stages, open bars, exquisite cuisine, and...

In the news release, LEOTEK Demonstrates Physical AI for Safer and Smarter Roadways at ITS America 2026, issued 12-Jun-2026 by LEOTEK over PR Newswire, we are advised by the company that the photo...

The United States is projected to face a shortage of 950 FTE urologists in 2026, a gap that is expected to more than double over the next decade. To better understand the factors contributing to...

Braeburn today announced it will present two oral presentations and two posters at the 88th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), taking place June...